UltraGreen.ai
Ultragreen.ai’s stabilising manager buys 2.3 million shares in fifth stabilising action since IPO
Citigroup Global Markets Singapore has now bought around 17.7 million shares of the medical technology company’s shares
Will UltraGreen.ai be able to shine in a market dominated by big, dividend-paying companies?
As the newly listed stock slides below its IPO price, DFI Retail Group is soaring on plans to boost its profitability and lift its dividend payout ratio
UOBKH initiates coverage on UltraGreen.ai with ‘buy’ on optimistic growth outlook
The company is well-positioned to benefit from potential expansion in the fluorescence-guided surgery market, say UOBKH analysts
UltraGreen.ai closes up 4.8% on SGX trading debut in largest non-Reit IPO since 2017
It ends the day US$0.07 higher at US$1.52 after hitting a high of US$1.62 in the morning
UltraGreen.ai’s post-IPO performance is an important gauge of investor interest
It represents the kind of high-tech players that investors have been clamouring to see listed on the local bourse
UltraGreen.ai’s 5.9 million share public offer 4.5 times subscribed
Its international offering was about 14.1 times subscribed
UltraGreen.ai right to move fast on Singapore listing instead of waiting for SGX-Nasdaq bridge
To drive its post-listing performance, the company should educate investors, lay out operational milestones and emphasise its competitive advantage
Surgical tech firm UltraGreen.ai files for US$377.1 million IPO on SGX mainboard
It is offering 112.1 million shares at US$1.45 or S$1.892 apiece; this includes 5.9 million shares for a retail tranche in Singapore
UltraGreen.ai aims to raise US$400 million in Singapore IPO, term sheet shows
The company is building an AI-powered surgical intelligence platform
UltraGreen.ai starts pre-marketing of over S$300 million Singapore IPO: sources
The planned share sale would add momentum to Republic’s efforts to attract high-growth companies and boost its capital markets
